Skip to content

1. General

This Privacy Policy describes how Exeltis USA, Inc. as part of Exeltis Pharmaceuticals Holding, S.L. and all its subsidiaries located in Spain, EU or third countries (hereinafter, jointly referred to as “Exeltis”) processes the information collected from you (the “User”) when registering or navigating through the website https://slynd.com (hereinafter, the “Website”), owned by Insud Pharma, S.L.U. Please read carefully this Privacy Policy as it contains important information concerning the personal data of Users and how we use it.

Exeltis and all its subsidiaries located in Spain, EU or third countries are globally known as Insud Pharma Group (hereinafter, “Insud Pharma Group”). Please find additional information about Insud Pharma Group and a non-exhaustive list of Exeltis subsidiaries here

Exeltis dedicates all its efforts to respect the privacy and security of the Users and undertakes to use personal data in accordance with the national data protection law.

In any event, EU General Data Protection Regulation (“GDPR”) provisions shall be applied to personal data processing carried out at a global level in accordance with Insud Pharma Group internal policies.

2. Categories of personal data and purposes of the processing

Users may use some functionalities of the Website without having to provide Exeltis any personal data. However, for certain functions, Users shall provide personal data in order to register for certain services, receive newsletters or other information of interest. In addition to the information you provide directly to Exeltis, we collect certain information when you visit our Website.

Personal data collected through the Website will be duly incorporated in databases under the responsibility of Exeltis which will be registered in Exeltis’ record of processing activities.

We also inform the Users that fields requested in forms marked with an asterisk are mandatory. In this sense, if the requested information is not provided, we will not be able to carry out the service.

Below, we have specified the categories of personal data we collect, the purposes for which we use such data and how long we will keep the personal data:

A. Users communications and customer service

This category includes any personal data provided by the User during their communications with Exeltis for the purpose of solving any incident or claim. In this sense, if the User has made any request or suggestion through our contact forms, we will process the personal data in order to answer it.

The legal basis for the processing of these personal data is consent when the Users provide their data through the contact forms.

B. Contact with nurse professionals.

The Website enables Users to contact our nurses in order to provide you further information, solve any doubts or any questions regarding the use of Slynd. To do so, Users may contact through the contact channels enabled on the Website for this purpose.

Nurses team is duly qualified and provide these services in accordance with the requirements of the applicable regulations. In no case shall the information provided by nurses as a medical diagnosis or recommendations for making medical decisions about User’s health. For an individual diagnosis and advice, Users shall contact their personal healthcare professionals.

The information collected on the occasion of the consultations will be kept confidential for the time strictly necessary to fulfil the purpose described. Once your consultation has been duly attended to, your data will be deleted.

The legal basis for the processing of this personal data is the consent of the Users when they provide their data through the contact channels provided.

C. Pharmacovigilance

The information provided by the User spontaneously or through contact channels for the processing and reporting of any adverse effect or reaction will be processed by Exeltis and Insud Pharma Group in order to comply with pharmacovigilance legal requirements, follow-up possible adverse reactions and solve any query that may be raised by Users.

If necessary, your data may be shared, prior anonymized, with the competent health authorities, companies which hold a marketing authorization of the product or other entities of the Insud Pharma Group.

The legal basis for the processing of this personal data is the consent given by Users when providing their personal data spontaneously or submitting the forms provided for these purposes, as well as for compliance with legal obligations regarding drug safety and pharmacovigilance.

D. Newsletter and commercial communications

If you subscribe to any of our notification or messaging services, we will use the email address provided by the User to provide the service. If the User has subscribed to any product, service or functionality, we may also communicate with the User to inform him or her of other similar products or candidatures that may be of interest.

If the User no longer wishes to receive e-mails, he or she may unsubscribe at any time by using the opt-out feature enabled in each e-mail message or by contacting us at dataprotection@insudpharma.com.

The legal basis for this processing is consent, when the User checks the box implemented in the specific form. Likewise, Exeltis, based on its legitimate interest, may send the Users or customers information about products and services. We will delete your email address once you have opted-out, unless it is also used for any other purposes listed in this Privacy Policy.

E. Marketing

Information about Users online searches (clicks and views), settings on our Website, requests for information and / or their contact history may be subject to processing by Exeltis. This information allows us to use different means to manage the relations with our customers and commercialize our products and services through e-mail or online advertising which may include customizing the content of the Website and offers in order to suit User preferences.

You may at any time object to this processing (for more information on how to do this, please read sections 7 and 8).

We use this personal data based on our legitimate interest in order to improve our products and services. Personal data will generally be deleted or anonymised 1 month after your last visit to our Website, except where we are legally required to keep the personal data or where it is retained for any other purpose.

F. Information about the use of our Website

Exeltis collects information automatically obtained by the Website related to the identification of the User’s computer equipment, use and navigation habits.

Said information includes data regarding language, pages or sections of the Website, keywords, date, time, amount of time the User expends in certain types of webpages, which section of the page he has visited, and similar information related to the use of the Website. Exeltis may collect this information using cookies. To obtain additional information please visit our Cookies Policy.

We use this personal data based on our legitimate interest in order to improve our products and services. We will keep the Personal Data for 1 month from the date of the last visit to the Website.

Exeltis may combine your personal data with other information provided by the User or collected from the Website as above mentioned. In those cases, all combined information will be processed as personal data during the period the information remains combined.

G. Services maintenance and optimization

Users’ personal data will also be used for the maintenance and analysis of our Website, solve any problem, improve availability and protect the Website against fraud (e.g. in case of repeated log attempts or non-compliance with our terms and conditions, e.g. by persons under the legal age). Analytics also allow us to check whether the online services we offer work effectively in order to improve them whenever possible.

The use of User’s personal data for these purposes is necessary based on our legitimate interest and will be retained for the expiration periods detailed in our Cookies Policy.

H. Comply with our legal obligation

We may need to process your personal data to comply with legal obligations binding or accepted by us. Likewise, we may need to provide information to and as required by local law enforcement agencies, other government authorities, or otherwise required by law or to protect the rights and safety of our property, company, employees and customers.

3. How we share personal data
Sometimes it is necessary to share your personal data with other Exeltis subsidiaries, companies of the Insud Pharma Group or third parties in order to guarantee the correct provision of the Website. We may share such information with the following:

  • Insud Pharma Group companies due to the use of shared computer systems, which may be located in the European Economic Area (EEA) or in third countries.
  • Business partners who offer products or services jointly with Exeltis.
  • Service providers, to the extent necessary for the provision of a service.

Such entities may be located in the United States, other countries in the European Economic Area or anywhere else in the world. When we keep personal data outside the EEA, we guarantee an adequate level of protection of the transferred data. To this purpose, we require service providers to take appropriate measures to protect the confidentiality and security of personal data.

For example, for services provided by providers outside the European Economic Area, we use Standard Model Clauses approved by the European Commission.

Exeltis may disclose User’s personal data to any public administration, when required by law and compelled to do so by such authorities. All data communications will always be carried out in compliance with the national data protection law in force and where applicable the GDPR.

4. Security

Exeltis cares to ensure the security and confidentiality of the Users personal data. Therefore, we have implemented several security measures and technical means to prevent the loss, misuse or access to the personal data without the User permission in accordance with the national data protection laws and the GDPR.

Nevertheless, it is also the User responsibility to control his or her personal information, therefore Exeltis asks and encourages all Users to be careful sharing information and content. Exeltis shall not control the content and information the User chooses to share with other Users and, therefore, Exeltis is not responsible for the consequences of the Users own actions.

Exeltis pledges (i) to act rapidly and in a responsible manner in the event the Users personal data security is deemed at risk, and (ii) to report it if relevant with the greatest diligence.

In case of a personal data breach, Exeltis undertakes to notify the relevant data protection authority without undue delay after becoming aware of such breach. Likewise, when the personal data breach is likely to result in a high risk to the rights and freedoms of Users, Exeltis will communicate the personal data breach and the measures taken to mitigate the risks and adverse effects to Users.

5. Cookies

Much of the information referred to in this Privacy Policy is collected through the use of cookies. Cookies are small text files containing small amounts of information that are downloaded and can be stored on your user device, for example, your computer, smartphone or tablet. These cookies are sometimes necessary to remember your account settings, language and country, but they also allow us to track and analyse Users behaviour on our Website and to display personalised advertisements on our Website or on third party websites. Where necessary, you will be asked to consent to the use of cookies. To obtain additional information on how cookies are used on the Website and its deactivation please visit the Cookies Policy.

6. Minors
The Website is not intended to be used by persons under the legal age. Under no circumstances will Exeltis voluntarily collect personal data from persons under the legal age.

7. Users rights concerning data protection

At any time, Users may exercise before Exeltis their data protection rights, in particular the right of access, rectification, restriction of processing, erasure, objection and portability pursuant to the applicable legislation. This means Users can ask what personal data we have about them, update, or they can request that Exeltis stops using data for a specific purpose, or simply require Exeltis to delete all personal data from our files and databases among other.

In the event the User decides to object to the processing of the personal data, Exeltis will no longer process personal data in connection to such User. Personal data may still be processed for the purposes established in data protection legislation or bring defence against legal claims.

After the User exercises any of the abovementioned rights, and during Exeltis verification period, all personal data will be kept blocked. The blocking procedure will prevent Exeltis from processing or erasing such personal data.

For the exercise of any of the abovementioned rights, the User shall contact Exeltis by email, addressing the request to dataprotection@insudpharma.com, indicating as reference: “EXERCISE OF RIGHTS” and identifying at the right to be exercised. In addition, Users may also lodge a claim before the relevant data protection authority if they consider that we have not processed their personal data in accordance with the regulations.

8. Users erasure right

As User, at any time you have the possibility to exercise your right to object to the processing of your personal data by sending an email to dataprotection@insudpharma.com with the subject “DATA ERASURE”.

9. Privacy policy updates

Exeltis reserves the right, at our sole discretion, to modify or replace this Privacy Policy. Your continued use of the Website after any such changes constitutes your acceptance of the new Privacy Policy.

Please review this agreement every so often in order to acknowledge any possible modifications. If you do not accept this document, partially or as a whole, or any subsequent modification, please refrain from the use, access or continue to access the Website or discontinue any use of the Website immediately.

10. Contact
If you have any further questions about the use of your personal data or about our Privacy Policy, you can contact Insud Pharma’s Group Data Protection Officer by email through dataprotection@insudpharma.com.

Slynd® Important Risk Information


Slynd does not protect against HIV infection (AIDS) and other sexually transmitted diseases (STDs).
What is Slynd?
SLYND is a birth control pill (oral contraceptive) that is used by females who can become pregnant to prevent pregnancy.
The progestin drospirenone may increase potassium levels in your blood. You should not take SLYND if you have kidney, liver or adrenal disease because this could cause serious heart problems as well as other health problems. Other medicines may also increase potassium levels in your blood. If you are currently on daily, long-term treatment for a chronic health condition with any of the medicines listed below, talk to your healthcare provider about whether SLYND is right for you. If you take any of the medicines listed below for a chronic health condition you should have a blood test to check the potassium level in your blood before you start taking SLYND and during the first month that you take SLYND.

Slynd® Important Risk Information


Slynd does not protect against HIV infection (AIDS) and other sexually transmitted diseases (STDs).

What is SLYND?

SLYND is a birth control pill (oral contraceptive) that is used by females who can become pregnant to prevent pregnancy.

The progestin drospirenone may increase potassium levels in your blood. You should not take SLYND if you have kidney, liver or adrenal disease because this could cause serious heart problems as well as other health problems. Other medicines may also increase potassium levels in your blood. If you are currently on daily, long-term treatment for a chronic health condition with any of the medicines listed below, talk to your healthcare provider about whether SLYND is right for you. If you take any of the medicines listed below for a chronic health condition you should have a blood test to check the potassium level in your blood before you start taking SLYND and during the first month that you take SLYND.

  • medicines to treat fungal infections, such as ketoconazole, itraconazole, or voriconazole
  • medicines to treat Human Immunodeficiency Virus (HIV) infection or Hepatitis C infection, such as indinavir or boceprevir
  • clarithromycin

Do not take SLYND if you:

  • have kidney disease or kidney failure.
  • have reduced adrenal gland function.
  • have or have had cervical cancer or any cancer that is sensitive to female hormones.
  • have liver disease, including liver tumors.
  • have unexplained vaginal bleeding.

Tell your healthcare providers if you have or have had any of these conditions. Your healthcare provider can suggest a different method of birth control.

If any of these conditions happen while you are taking SLYND, stop taking SLYND right away and talk to your healthcare provider. Use non-hormonal contraception when you stop taking SLYND.

Before you take SLYND, tell your healthcare provider about all of your medical conditions, including if you:

  • are pregnant or think you may be pregnant.
  • have ever had blood clots in your legs (deep vein thrombosis), lungs (pulmonary embolism), or a stroke or heart attack (myocardial infarction).
  • have or have had depression.

Tell your healthcare providers about all the medicines you take including prescription and over-the-counter medicines, vitamins and herbal supplements, such as St. John’s Wort. SLYND may affect the way other medicines work, and other medicines may affect how well SLYND works.

What are the possible serious side effects of SLYND?

SLYND may cause serious side effects, including:

  • High potassium levels in your blood (hyperkalemia). Certain medicines and conditions can also increase the potassium levels in your blood. Your healthcare provider may check the potassium levels in your blood before and during treatment with SLYND. Call your healthcare provider or go to a hospital emergency room right away if you have signs or symptoms of high potassium levels in your blood including:
    • weakness or numbness in an arm or leg.
    • palpitations (feel like your heart is racing or fluttering) or irregular heartbeat.
    • nausea.
    • vomiting.
    • severe pain in your chest.
    • shortness of breath.
  • Blood clot forming in blood vessels. Tell your healthcare provider if you have had a blood clot. Tell your healthcare provider if you plan to have surgery or are not able to be active due to illness or injury. Call your healthcare provider or go to a hospital or emergency room right away if you have:
    • leg pain that will not go away.
    • a sudden, severe headache unlike your usual headaches.
    • sudden, severe shortness of breath.
    • sudden change in vision or blindness.
    • chest pain.
    • weakness or numbness in your arm or leg.
    • trouble speaking.
  • Bone loss.
  • Cervical Cancer.
  • Liver problems, including liver tumors.
  • Ectopic pregnancy (pregnancy in your tubes). This is a medical emergency that often requires surgery. If you have severe abdominal pain, call your healthcare provider or go to a hospital emergency room right away.
  • Risk of high blood sugar levels in people with diabetes.
  • Changes in menstrual bleeding. Tell your doctor if you have changes in menstrual bleeding.
  • Depression, especially if you have had depression in the past.

What are the most common side effects of SLYND?

  • acne
  • headache
  • breast pain and tenderness
  • weight gain
  • menstrual cramps
  • nausea
  • severe vaginal bleeding
  • less sexual desire

These are not all the possible side effects of SLYND.

What else should I know about taking SLYND?

If you are scheduled for any lab tests, tell your healthcare provider you are taking SLYND. Certain blood tests may be affected by SLYND.

These are not all the possible side effects and risks of SLYND. Please click here to read full Prescribing Information before starting SLYND.

Are you a healthcare professional?

You are entering a page reserved for U.S. healthcare professionals only. By clicking on “Yes” below, you are confirming that you are a healthcare professional and wish to enter this page.

Yes, I am

If you are a Canadian healthcare professional, please visit slynd.ca

Go to slynd.ca

You're about to continue to our partner site

You are now leaving Slynd.com to visit a website that is not owned or operated by Exeltis USA, Inc. Links to outside sites are provided as a resource to our visitors and do not imply an endorsement or recommendation of a particular healthcare provide by Exeltis, nor an endorsement of any Exeltis product by any healthcare provider.

Exeltis accepts no responsibility or liability for the content or services of other websites. All prescription decisions are at the sole discretion of the healthcare provider based on each patient’s individual needs.

Proceed to Nurx